Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Jan 17, 2025Jan 18, 2025Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$0.58$17,773-40.84%
Jan 13, 2025Jan 15, 2025Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$0.58$34,639-58.89%
Jan 16, 2024Jan 17, 2024Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$0.7$27,594-46.76%
Jan 11, 2024Jan 12, 2024Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$0.85$24,734-52.53%
Sep 01, 2023Sep 01, 2023Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$0.78$1,874-41.06%
Jun 27, 2023Jun 28, 2023Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$0.92$2,146-39.87%
Jan 17, 2023Jan 18, 2023Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$1.86$18,686-42.96%
Jan 11, 2023Jan 13, 2023Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$1.72$54,791-56.11%
Jan 04, 2023Jan 05, 2023Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$1.69$8,594-43.34%
Sep 01, 2022Sep 02, 2022Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$1.97$4,993-43.34%
Jun 27, 2022Jun 28, 2022Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$1.63$4,176-43.78%
Jan 18, 2022Jan 19, 2022Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$3.19$35,416-47.40%
Jan 11, 2022Jan 14, 2022Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$3.55$61,877-83.84%
Jan 04, 2022Jan 06, 2022Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$4.06$22,483-47.27%
Sep 01, 2021Sep 02, 2021Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$5.2$14,452-47.54%
Jun 28, 2021Jun 29, 2021Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$4.37$12,210-47.74%
Jan 19, 2021Jan 20, 2021Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$5.67$56,009-42.20%
Jan 12, 2021Jan 13, 2021Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$6.15$16,654-42.28%
Jan 04, 2021Jan 06, 2021Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$5.33$26,464-42.44%
Sep 01, 2020Sep 03, 2020Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$8.51$23,637-47.44%
Aug 03, 2020Aug 05, 2020Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$9.25$25,789-47.64%
Jan 14, 2020Jan 16, 2020Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$5.13$16,616-50.55%
Jan 06, 2020Jan 08, 2020Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$1.2$7,080-50.41%
Jan 14, 2019Jan 17, 2019Rawcliffe Adrian
CFO
SellAdaptimmune Therapeutics PlcADAP$5.37$16,559-48.17%
Mar 20, 2018Mar 23, 2018Rawcliffe Adrian
CFO
SellAdaptimmune Therapeutics PlcADAP$1.71$1M-0